Follow
Clinical Diagnostics
Clinical Diagnostics: The identification of a disease in regards to a patient's complaints based merely on signs, symptoms, and medical history of the patient rather than on laboratory examination or medical imaging.
-
OCT 24, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...OCT 18, 2023 | 9:00 AM
In this webinar, Jenny Meredith, Ph.D., HCLD(ABB), Clinical Microbiology Director at Prisma Health-Upstate joins forces with Sara Ezra, Molecular Supervisor at Pathology Consultants (subsidi...OCT 17, 2023 | 6:00 AM
During this presentation, the speaker will provide insights into the clinical utility of the T2Bacteria and T2Resistance Panels in the intensive care unit (ICU), including real-world clinica...OCT 12, 2023 | 6:00 AM
Acute coughing is one of the most common reasons for consulting in primary care thus driving considerable antibiotic use and health-care costs. Currently, identification of microbial etiolog...Speaker: Prof. Dr. Greet Ieven, PhD , Israel Figueroa , Jelena Feenstra, PhDSponsored By: Thermo Fisher ScientificOCT 11, 2023 | 9:00 PM
Epigenetic modifications such as DNA methylation have long shown promise as potential biomarkers to diagnose and guide treatment of many human diseases, including multiple types of cancers....Speaker: Dr. Lucia Anna Muscarella, Ph.D. , Dr. Cristina Guillén, Ph.D.Sponsored By: Thermo Fisher ScientificOCT 10, 2023 | 9:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...OCT 10, 2023 | 1:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...OCT 05, 2023 | 1:00 AM
Organoids continue to gain traction in drug discovery efforts as they offer a more biologically relevant disease model than traditional approaches. But they aren't without challenges. Jo...SEP 26, 2023 | 6:00 AM
Troubleshooting is a systematic approach designed to correct problems that may occur with patient samples, instruments, operating an analyzer, handling, reagents and quality control material...SEP 20, 2023 | 11:00 AM
Preanalytical errors and unsuitable samples can account for up to 70% of lab errors. 1 These errors can be attributed to improper specimen collection, specimen transportation, and specimen p...SEP 14, 2023 | 10:00 AM
In this webinar, Victoria Quiett of Thermo Fisher Scientific will dive into a comprehensive look at key components of running Pharmacogenomics (PGx) in your lab. The webinar will discuss the...SEP 14, 2023 | 9:00 AM
Clinical laboratories generate most of the objective data on which diagnostic, preventive, and therapeutic decisions are made. By considering the current availability of information analytic...
SEP 14, 2023 | 9:00 AM
Small extracellular vesicles (EVs) and Exosomes released by cells, have gained significant interest in biomedical research due to their potential applications in diagnostics and therapeutics...
SEP 13, 2023 | 10:00 AM
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research​
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
September 13 at 10:00am CEST, 9:00am BST
Webinar airing too early or too late for you? This webinar will also be available: September 13 at 10:00am PDT, 1:00pm EDT https://www.labroots.com/ms/webinar/dpcr-liquidbiopsy-panel-2 and S...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research​
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
September 13 at 9:30am IST, 12:00pm CST/SGT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research​
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
SEP 07, 2023 | 8:00 AM
Advancements in Next Generation Sequencing (NGS) are changing the genomics industry, favoring those with scale. Quest Diagnostics' clinical expertise, combined with our infrastructure, p...
Speaker:
Ryan Serra, BSc. and Ph.D.
, Matthew Gallen, MPH
, Sameer Vasantgadkar
Sponsored By: Covaris, Inc.
AUG 24, 2023 | 8:30 PM
When building your own infectious disease molecular panels there are many paths to consider. In this interview, we ask Marcus Cognetti and Dr. Ari Frenkel what approach is required to create...
AUG 17, 2023 | 8:00 AM
Globally millions of individuals get sick, hundreds of thousands are hospitalized, and tens of thousands die from respiratory viruses such as Influenza and Respiratory Syncytial Virus (RSV)...
JUL 25, 2023 | 8:00 PM
NEED ABSTRACT Learning Objectives Understand how the challenges of amplification from low input DNA, including single cells, can be overcome Discover why more researchers are using a next ge...
JUN 28, 2023 | 8:00 AM
Laboratories performing diagnostic testing for infectious diseases have an obligation to meet the needs of multiple patient populations. With infectious disease, time it takes for reporting...
JUN 27, 2023 | 10:00 AM
There is a great variability in testing for monoclonal gammopathies. During his presentation, Dr. David F. Keren, MD, Clinical Professor of Pathology at University of Michigan Health, descri...
JUN 22, 2023 | 11:00 AM
When building your own infectious disease molecular panels there are many paths to consider. In this interview, we ask Marcus Cognetti and Dr. Ari Frenkel what approach is required to create...
JUN 21, 2023 | 11:00 AM
A lot of exciting things are going on within the health care sector and AI [artificial intelligence] is playing a major role. AI is becoming increasingly popular in medicine and healthcare,...
Speaker:
Priv.-Doz. Dr. med. Ulrike Schumacher
, Dr. Steven Giglio
Sponsored By: Thermo Fisher Scientific
OCT 24, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 18, 2023 | 9:00 AM
In this webinar, Jenny Meredith, Ph.D., HCLD(ABB), Clinical Microbiology Director at Prisma Health-Upstate joins forces with Sara Ezra, Molecular Supervisor at Pathology Consultants (subsidi...
OCT 17, 2023 | 6:00 AM
During this presentation, the speaker will provide insights into the clinical utility of the T2Bacteria and T2Resistance Panels in the intensive care unit (ICU), including real-world clinica...
OCT 12, 2023 | 6:00 AM
Acute coughing is one of the most common reasons for consulting in primary care thus driving considerable antibiotic use and health-care costs. Currently, identification of microbial etiolog...
Speaker:
Prof. Dr. Greet Ieven, PhD
, Israel Figueroa
, Jelena Feenstra, PhD
Sponsored By: Thermo Fisher Scientific
OCT 11, 2023 | 9:00 PM
Epigenetic modifications such as DNA methylation have long shown promise as potential biomarkers to diagnose and guide treatment of many human diseases, including multiple types of cancers....
Speaker:
Dr. Lucia Anna Muscarella, Ph.D.
, Dr. Cristina Guillén, Ph.D.
Sponsored By: Thermo Fisher Scientific
OCT 10, 2023 | 9:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
OCT 10, 2023 | 1:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
OCT 05, 2023 | 1:00 AM
Organoids continue to gain traction in drug discovery efforts as they offer a more biologically relevant disease model than traditional approaches. But they aren't without challenges. Jo...
SEP 26, 2023 | 6:00 AM
Troubleshooting is a systematic approach designed to correct problems that may occur with patient samples, instruments, operating an analyzer, handling, reagents and quality control material...
SEP 20, 2023 | 11:00 AM
Preanalytical errors and unsuitable samples can account for up to 70% of lab errors. 1 These errors can be attributed to improper specimen collection, specimen transportation, and specimen p...
SEP 14, 2023 | 10:00 AM
In this webinar, Victoria Quiett of Thermo Fisher Scientific will dive into a comprehensive look at key components of running Pharmacogenomics (PGx) in your lab. The webinar will discuss the...
SEP 14, 2023 | 9:00 AM
Clinical laboratories generate most of the objective data on which diagnostic, preventive, and therapeutic decisions are made. By considering the current availability of information analytic...
SEP 14, 2023 | 9:00 AM
Small extracellular vesicles (EVs) and Exosomes released by cells, have gained significant interest in biomedical research due to their potential applications in diagnostics and therapeutics...
SEP 13, 2023 | 10:00 AM
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research​
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
September 13 at 10:00am CEST, 9:00am BST
Webinar airing too early or too late for you? This webinar will also be available: September 13 at 10:00am PDT, 1:00pm EDT https://www.labroots.com/ms/webinar/dpcr-liquidbiopsy-panel-2 and S...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research​
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
September 13 at 9:30am IST, 12:00pm CST/SGT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research​
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
SEP 07, 2023 | 8:00 AM
Advancements in Next Generation Sequencing (NGS) are changing the genomics industry, favoring those with scale. Quest Diagnostics' clinical expertise, combined with our infrastructure, p...
Speaker:
Ryan Serra, BSc. and Ph.D.
, Matthew Gallen, MPH
, Sameer Vasantgadkar
Sponsored By: Covaris, Inc.
AUG 24, 2023 | 8:30 PM
When building your own infectious disease molecular panels there are many paths to consider. In this interview, we ask Marcus Cognetti and Dr. Ari Frenkel what approach is required to create...
AUG 17, 2023 | 8:00 AM
Globally millions of individuals get sick, hundreds of thousands are hospitalized, and tens of thousands die from respiratory viruses such as Influenza and Respiratory Syncytial Virus (RSV)...
JUL 25, 2023 | 8:00 PM
NEED ABSTRACT Learning Objectives Understand how the challenges of amplification from low input DNA, including single cells, can be overcome Discover why more researchers are using a next ge...
JUN 28, 2023 | 8:00 AM
Laboratories performing diagnostic testing for infectious diseases have an obligation to meet the needs of multiple patient populations. With infectious disease, time it takes for reporting...
JUN 27, 2023 | 10:00 AM
There is a great variability in testing for monoclonal gammopathies. During his presentation, Dr. David F. Keren, MD, Clinical Professor of Pathology at University of Michigan Health, descri...
JUN 22, 2023 | 11:00 AM
When building your own infectious disease molecular panels there are many paths to consider. In this interview, we ask Marcus Cognetti and Dr. Ari Frenkel what approach is required to create...
JUN 21, 2023 | 11:00 AM
A lot of exciting things are going on within the health care sector and AI [artificial intelligence] is playing a major role. AI is becoming increasingly popular in medicine and healthcare,...
Speaker:
Priv.-Doz. Dr. med. Ulrike Schumacher
, Dr. Steven Giglio
Sponsored By: Thermo Fisher Scientific